rewirebio.iobenchmarks
Dataset

EpiPanGI Dx plasma cfDNA targeted bisulfite methylation (GSE149438, 300 samples)

Plasma cfDNA targeted bisulfite sequencing of 254 gastrointestinal cancers and 46 non-cancer controls from the EpiPanGI Dx study.

Evaluation results

5 evaluations · 15 results. Different protocols are not a single leaderboard.

Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: CpGPT Cancer-100M fine-tuned on 20,499 DMR-informed CpGsProtocol: Xu and Feng 2026: GI cancer vs non-cancer on GSE149438, three train-validation-test split-runs, DMR-informed CpG features
Dataset: EpiPanGI Dx plasma cfDNA targeted bisulfite methylation (GSE149438, 300 samples)
0.996 AUPRC (GI cancer vs non-cancer, held-out test partition, mean over three split-runs)
unitless · higher

Uncertainty: 95% CI 0.9950 to 0.9970. Across three split-runs, bounded to the valid range 0 to 1 (Table 3 footnote)

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

CpGPT on GSE149438 DMR-informed split-runs (Xu and Feng 2026)

ctdnalit-20261011-cpgpt2026-protocol-dmr-informed-split-runs

Aggregation: Not reported

An Evaluation of DMR-Informed Fine-Tuning of Tissue Array-Pretrained CpGPT for Gastrointestinal Cancer Classification Using cfDNA Targeted Methylation · Table 3, row 'CpGPT', column 'Test AUPRC'
Configuration: CpGPT Cancer-100M fine-tuned on 20,499 DMR-informed CpGsProtocol: Xu and Feng 2026: GI cancer vs non-cancer on GSE149438, three train-validation-test split-runs, DMR-informed CpG features
Dataset: EpiPanGI Dx plasma cfDNA targeted bisulfite methylation (GSE149438, 300 samples)
0.99 AUROC (GI cancer vs non-cancer, held-out test partition, mean over three split-runs)
unitless · higher

Uncertainty: 95% CI 0.9715 to 1.0000. Across three split-runs, bounded to the valid range 0 to 1 (Table 3 footnote)

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

CpGPT on GSE149438 DMR-informed split-runs (Xu and Feng 2026)

ctdnalit-20261011-cpgpt2026-protocol-dmr-informed-split-runs

Aggregation: Not reported

An Evaluation of DMR-Informed Fine-Tuning of Tissue Array-Pretrained CpGPT for Gastrointestinal Cancer Classification Using cfDNA Targeted Methylation · Table 3, row 'CpGPT', column 'Test AUROC'
Configuration: CpGPT Cancer-100M fine-tuned on 20,499 DMR-informed CpGsProtocol: Xu and Feng 2026: GI cancer vs non-cancer on GSE149438, three train-validation-test split-runs, DMR-informed CpG features
Dataset: EpiPanGI Dx plasma cfDNA targeted bisulfite methylation (GSE149438, 300 samples)
0.949 AUROC (GI cancer vs non-cancer, validation partition, mean over three split-runs)
unitless · higher

Uncertainty: 95% CI 0.8887 to 1.0000. Across three split-runs, bounded to the valid range 0 to 1 (Table 3 footnote)

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

CpGPT on GSE149438 DMR-informed split-runs (Xu and Feng 2026)

ctdnalit-20261011-cpgpt2026-protocol-dmr-informed-split-runs

Aggregation: Not reported

An Evaluation of DMR-Informed Fine-Tuning of Tissue Array-Pretrained CpGPT for Gastrointestinal Cancer Classification Using cfDNA Targeted Methylation · Table 3, row 'CpGPT', column 'Validation AUROC'
Configuration: Elastic Net on 20,499 DMR-informed CpGs (caret)Protocol: Xu and Feng 2026: GI cancer vs non-cancer on GSE149438, three train-validation-test split-runs, DMR-informed CpG features
Dataset: EpiPanGI Dx plasma cfDNA targeted bisulfite methylation (GSE149438, 300 samples)
0.981 AUPRC (GI cancer vs non-cancer, held-out test partition, mean over three split-runs)
unitless · higher

Uncertainty: 95% CI 0.9494 to 1.0000. Across three split-runs, bounded to the valid range 0 to 1 (Table 3 footnote)

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Elastic Net on GSE149438 DMR-informed split-runs (Xu and Feng 2026)

ctdnalit-20261011-cpgpt2026-protocol-dmr-informed-split-runs

Aggregation: Not reported

An Evaluation of DMR-Informed Fine-Tuning of Tissue Array-Pretrained CpGPT for Gastrointestinal Cancer Classification Using cfDNA Targeted Methylation · Table 3, row 'Elastic Net', column 'Test AUPRC'
Configuration: Elastic Net on 20,499 DMR-informed CpGs (caret)Protocol: Xu and Feng 2026: GI cancer vs non-cancer on GSE149438, three train-validation-test split-runs, DMR-informed CpG features
Dataset: EpiPanGI Dx plasma cfDNA targeted bisulfite methylation (GSE149438, 300 samples)
0.942 AUROC (GI cancer vs non-cancer, held-out test partition, mean over three split-runs)
unitless · higher

Uncertainty: 95% CI 0.8587 to 1.0000. Across three split-runs, bounded to the valid range 0 to 1 (Table 3 footnote)

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Elastic Net on GSE149438 DMR-informed split-runs (Xu and Feng 2026)

ctdnalit-20261011-cpgpt2026-protocol-dmr-informed-split-runs

Aggregation: Not reported

An Evaluation of DMR-Informed Fine-Tuning of Tissue Array-Pretrained CpGPT for Gastrointestinal Cancer Classification Using cfDNA Targeted Methylation · Table 3, row 'Elastic Net', column 'Test AUROC'
Configuration: Elastic Net on 20,499 DMR-informed CpGs (caret)Protocol: Xu and Feng 2026: GI cancer vs non-cancer on GSE149438, three train-validation-test split-runs, DMR-informed CpG features
Dataset: EpiPanGI Dx plasma cfDNA targeted bisulfite methylation (GSE149438, 300 samples)
0.93 AUROC (GI cancer vs non-cancer, validation partition, mean over three split-runs)
unitless · higher

Uncertainty: 95% CI 0.7928 to 1.0000. Across three split-runs, bounded to the valid range 0 to 1 (Table 3 footnote)

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Elastic Net on GSE149438 DMR-informed split-runs (Xu and Feng 2026)

ctdnalit-20261011-cpgpt2026-protocol-dmr-informed-split-runs

Aggregation: Not reported

An Evaluation of DMR-Informed Fine-Tuning of Tissue Array-Pretrained CpGPT for Gastrointestinal Cancer Classification Using cfDNA Targeted Methylation · Table 3, row 'Elastic Net', column 'Validation AUROC'
Configuration: GBM on 20,499 DMR-informed CpGs (caret)Protocol: Xu and Feng 2026: GI cancer vs non-cancer on GSE149438, three train-validation-test split-runs, DMR-informed CpG features
Dataset: EpiPanGI Dx plasma cfDNA targeted bisulfite methylation (GSE149438, 300 samples)
0.955 AUPRC (GI cancer vs non-cancer, held-out test partition, mean over three split-runs)
unitless · higher

Uncertainty: 95% CI 0.9122 to 0.9978. Across three split-runs, bounded to the valid range 0 to 1 (Table 3 footnote)

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

GBM on GSE149438 DMR-informed split-runs (Xu and Feng 2026)

ctdnalit-20261011-cpgpt2026-protocol-dmr-informed-split-runs

Aggregation: Not reported

An Evaluation of DMR-Informed Fine-Tuning of Tissue Array-Pretrained CpGPT for Gastrointestinal Cancer Classification Using cfDNA Targeted Methylation · Table 3, row 'GBM', column 'Test AUPRC'
Configuration: GBM on 20,499 DMR-informed CpGs (caret)Protocol: Xu and Feng 2026: GI cancer vs non-cancer on GSE149438, three train-validation-test split-runs, DMR-informed CpG features
Dataset: EpiPanGI Dx plasma cfDNA targeted bisulfite methylation (GSE149438, 300 samples)
0.846 AUROC (GI cancer vs non-cancer, held-out test partition, mean over three split-runs)
unitless · higher

Uncertainty: 95% CI 0.7322 to 0.9602. Across three split-runs, bounded to the valid range 0 to 1 (Table 3 footnote)

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

GBM on GSE149438 DMR-informed split-runs (Xu and Feng 2026)

ctdnalit-20261011-cpgpt2026-protocol-dmr-informed-split-runs

Aggregation: Not reported

An Evaluation of DMR-Informed Fine-Tuning of Tissue Array-Pretrained CpGPT for Gastrointestinal Cancer Classification Using cfDNA Targeted Methylation · Table 3, row 'GBM', column 'Test AUROC'
Configuration: GBM on 20,499 DMR-informed CpGs (caret)Protocol: Xu and Feng 2026: GI cancer vs non-cancer on GSE149438, three train-validation-test split-runs, DMR-informed CpG features
Dataset: EpiPanGI Dx plasma cfDNA targeted bisulfite methylation (GSE149438, 300 samples)
0.877 AUROC (GI cancer vs non-cancer, validation partition, mean over three split-runs)
unitless · higher

Uncertainty: 95% CI 0.7917 to 0.9617. Across three split-runs, bounded to the valid range 0 to 1 (Table 3 footnote)

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

GBM on GSE149438 DMR-informed split-runs (Xu and Feng 2026)

ctdnalit-20261011-cpgpt2026-protocol-dmr-informed-split-runs

Aggregation: Not reported

An Evaluation of DMR-Informed Fine-Tuning of Tissue Array-Pretrained CpGPT for Gastrointestinal Cancer Classification Using cfDNA Targeted Methylation · Table 3, row 'GBM', column 'Validation AUROC'
Configuration: Random Forest on 20,499 DMR-informed CpGs (caret)Protocol: Xu and Feng 2026: GI cancer vs non-cancer on GSE149438, three train-validation-test split-runs, DMR-informed CpG features
Dataset: EpiPanGI Dx plasma cfDNA targeted bisulfite methylation (GSE149438, 300 samples)
0.948 AUPRC (GI cancer vs non-cancer, held-out test partition, mean over three split-runs)
unitless · higher

Uncertainty: 95% CI 0.8985 to 0.9965. Across three split-runs, bounded to the valid range 0 to 1 (Table 3 footnote)

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Random Forest on GSE149438 DMR-informed split-runs (Xu and Feng 2026)

ctdnalit-20261011-cpgpt2026-protocol-dmr-informed-split-runs

Aggregation: Not reported

An Evaluation of DMR-Informed Fine-Tuning of Tissue Array-Pretrained CpGPT for Gastrointestinal Cancer Classification Using cfDNA Targeted Methylation · Table 3, row 'Random Forest', column 'Test AUPRC'
Configuration: Random Forest on 20,499 DMR-informed CpGs (caret)Protocol: Xu and Feng 2026: GI cancer vs non-cancer on GSE149438, three train-validation-test split-runs, DMR-informed CpG features
Dataset: EpiPanGI Dx plasma cfDNA targeted bisulfite methylation (GSE149438, 300 samples)
0.841 AUROC (GI cancer vs non-cancer, held-out test partition, mean over three split-runs)
unitless · higher

Uncertainty: 95% CI 0.7573 to 0.9243. Across three split-runs, bounded to the valid range 0 to 1 (Table 3 footnote)

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Random Forest on GSE149438 DMR-informed split-runs (Xu and Feng 2026)

ctdnalit-20261011-cpgpt2026-protocol-dmr-informed-split-runs

Aggregation: Not reported

An Evaluation of DMR-Informed Fine-Tuning of Tissue Array-Pretrained CpGPT for Gastrointestinal Cancer Classification Using cfDNA Targeted Methylation · Table 3, row 'Random Forest', column 'Test AUROC'
Configuration: Random Forest on 20,499 DMR-informed CpGs (caret)Protocol: Xu and Feng 2026: GI cancer vs non-cancer on GSE149438, three train-validation-test split-runs, DMR-informed CpG features
Dataset: EpiPanGI Dx plasma cfDNA targeted bisulfite methylation (GSE149438, 300 samples)
0.793 AUROC (GI cancer vs non-cancer, validation partition, mean over three split-runs)
unitless · higher

Uncertainty: 95% CI 0.5946 to 0.9920. Across three split-runs, bounded to the valid range 0 to 1 (Table 3 footnote)

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Random Forest on GSE149438 DMR-informed split-runs (Xu and Feng 2026)

ctdnalit-20261011-cpgpt2026-protocol-dmr-informed-split-runs

Aggregation: Not reported

An Evaluation of DMR-Informed Fine-Tuning of Tissue Array-Pretrained CpGPT for Gastrointestinal Cancer Classification Using cfDNA Targeted Methylation · Table 3, row 'Random Forest', column 'Validation AUROC'
Configuration: SVM radial on 20,499 DMR-informed CpGs (caret)Protocol: Xu and Feng 2026: GI cancer vs non-cancer on GSE149438, three train-validation-test split-runs, DMR-informed CpG features
Dataset: EpiPanGI Dx plasma cfDNA targeted bisulfite methylation (GSE149438, 300 samples)
0.983 AUPRC (GI cancer vs non-cancer, held-out test partition, mean over three split-runs)
unitless · higher

Uncertainty: 95% CI 0.9488 to 1.0000. Across three split-runs, bounded to the valid range 0 to 1 (Table 3 footnote)

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

SVM radial on GSE149438 DMR-informed split-runs (Xu and Feng 2026)

ctdnalit-20261011-cpgpt2026-protocol-dmr-informed-split-runs

Aggregation: Not reported

An Evaluation of DMR-Informed Fine-Tuning of Tissue Array-Pretrained CpGPT for Gastrointestinal Cancer Classification Using cfDNA Targeted Methylation · Table 3, row 'SVM radial', column 'Test AUPRC'
Configuration: SVM radial on 20,499 DMR-informed CpGs (caret)Protocol: Xu and Feng 2026: GI cancer vs non-cancer on GSE149438, three train-validation-test split-runs, DMR-informed CpG features
Dataset: EpiPanGI Dx plasma cfDNA targeted bisulfite methylation (GSE149438, 300 samples)
0.957 AUROC (GI cancer vs non-cancer, held-out test partition, mean over three split-runs)
unitless · higher

Uncertainty: 95% CI 0.8736 to 1.0000. Across three split-runs, bounded to the valid range 0 to 1 (Table 3 footnote)

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

SVM radial on GSE149438 DMR-informed split-runs (Xu and Feng 2026)

ctdnalit-20261011-cpgpt2026-protocol-dmr-informed-split-runs

Aggregation: Not reported

An Evaluation of DMR-Informed Fine-Tuning of Tissue Array-Pretrained CpGPT for Gastrointestinal Cancer Classification Using cfDNA Targeted Methylation · Table 3, row 'SVM radial', column 'Test AUROC'
Configuration: SVM radial on 20,499 DMR-informed CpGs (caret)Protocol: Xu and Feng 2026: GI cancer vs non-cancer on GSE149438, three train-validation-test split-runs, DMR-informed CpG features
Dataset: EpiPanGI Dx plasma cfDNA targeted bisulfite methylation (GSE149438, 300 samples)
0.937 AUROC (GI cancer vs non-cancer, validation partition, mean over three split-runs)
unitless · higher

Uncertainty: 95% CI 0.8126 to 1.0000. Across three split-runs, bounded to the valid range 0 to 1 (Table 3 footnote)

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

SVM radial on GSE149438 DMR-informed split-runs (Xu and Feng 2026)

ctdnalit-20261011-cpgpt2026-protocol-dmr-informed-split-runs

Aggregation: Not reported

An Evaluation of DMR-Informed Fine-Tuning of Tissue Array-Pretrained CpGPT for Gastrointestinal Cancer Classification Using cfDNA Targeted Methylation · Table 3, row 'SVM radial', column 'Validation AUROC'

Source checking is not independent reproduction. Release 2026-11-21-c8bea25e5abb.

Research readiness

0 of 4 readiness checks met. These checks assess whether the evidence supports a reproducible investigation; a source-checked score alone does not meet them.

Readiness checks, gaps and artifacts

Release 2026-11-21-c8bea25e5abb · Evidence verified: Not verified

Evidence incomplete

Replay metrics

Exact outcomes, predictions, identifiers and evaluator are connected.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified

Verified: Not verified

Evidence incomplete

Investigate discrepancies

Replay evidence includes annotations and an assessment of dependence. Unknown independence permits descriptive analysis only.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified
  • Sample annotations are recorded: not yet verified
  • Dependence between samples is assessed: not yet verified

Verified: Not verified

Evidence incomplete

Run locally

A pinned recipe describes the inputs, environment and resource requirements.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • A pinned run recipe exists: not yet verified
  • Compute requirements are estimated: not yet verified

Verified: Not verified

Evidence incomplete

Validate independently

Separate data and exposure records support an independent test.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Independent validation data exist: not yet verified
  • Overlap with training data is checked: not yet verified

Verified: Not verified

Readiness describes the evidence in this release. Availability on your computer is checked separately when an investigation runs. Existing data exposure can prevent independent validation even when files are available.

Artifacts and reproduction

No verified artifact manifest is connected to this record yet. The gaps above identify what is needed before analysis can begin.

Dataset and evaluation context

A dataset supplies biological observations. The evaluation protocol defines how those observations are split, used and scored.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

11 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-c8bea25e5abb
Property and statementOriginal source and locationReview and provenance
Accession
GSE149438
Context-only references
An Evaluation of DMR-Informed Fine-Tuning of Tissue Array-Pretrained CpGPT for Gastrointestinal Cancer Classification Using cfDNA Targeted Methylation

Original source ↗

Methods, data sources and study cohorts; Table 1

Version: medRxiv version 1, posted 2026-07-29
Retrieved: 2026-10-11T21:49:59Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.accession

Source artifact SHA-256: 369746bfe0117866d294e01f49c6ffbfc2d177e347872030d6233e2e7366961e

Hash scope: artifact_sha256 describes one retrieval (2026-10-11T21:49:59Z). medRxiv regenerates this PDF: a reviewer download on 2026-10-12 had 2,761,577 bytes, SHA-256 3d37b32e8ff782201ed8ee6677a01808d4f8c86eea70350a530dde7306cab7c9 and PDF CreationDate 2026-10-11T20:08:12-07:00. The reviewer's copy's text layer matched every extracted value. The licence does not allow archiving.

Inspected artifact

Assay
Targeted bisulfite sequencing of plasma cfDNA
Context-only references
An Evaluation of DMR-Informed Fine-Tuning of Tissue Array-Pretrained CpGPT for Gastrointestinal Cancer Classification Using cfDNA Targeted Methylation

Original source ↗

Methods, data sources and study cohorts; Table 1

Version: medRxiv version 1, posted 2026-07-29
Retrieved: 2026-10-11T21:49:59Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.assay

Source artifact SHA-256: 369746bfe0117866d294e01f49c6ffbfc2d177e347872030d6233e2e7366961e

Hash scope: artifact_sha256 describes one retrieval (2026-10-11T21:49:59Z). medRxiv regenerates this PDF: a reviewer download on 2026-10-12 had 2,761,577 bytes, SHA-256 3d37b32e8ff782201ed8ee6677a01808d4f8c86eea70350a530dde7306cab7c9 and PDF CreationDate 2026-10-11T20:08:12-07:00. The reviewer's copy's text layer matched every extracted value. The licence does not allow archiving.

Inspected artifact

Negatives
46
Context-only references
An Evaluation of DMR-Informed Fine-Tuning of Tissue Array-Pretrained CpGPT for Gastrointestinal Cancer Classification Using cfDNA Targeted Methylation

Original source ↗

Methods, data sources and study cohorts; Table 1

Version: medRxiv version 1, posted 2026-07-29
Retrieved: 2026-10-11T21:49:59Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.negatives

Source artifact SHA-256: 369746bfe0117866d294e01f49c6ffbfc2d177e347872030d6233e2e7366961e

Hash scope: artifact_sha256 describes one retrieval (2026-10-11T21:49:59Z). medRxiv regenerates this PDF: a reviewer download on 2026-10-12 had 2,761,577 bytes, SHA-256 3d37b32e8ff782201ed8ee6677a01808d4f8c86eea70350a530dde7306cab7c9 and PDF CreationDate 2026-10-11T20:08:12-07:00. The reviewer's copy's text layer matched every extracted value. The licence does not allow archiving.

Inspected artifact

Population
74 PDAC, 48 ESCC, 43 HCC, 40 CRC, 37 gastric and 12 oesophageal adenocarcinoma cancers, and 46 non-cancer controls
Context-only references
An Evaluation of DMR-Informed Fine-Tuning of Tissue Array-Pretrained CpGPT for Gastrointestinal Cancer Classification Using cfDNA Targeted Methylation

Original source ↗

Methods, data sources and study cohorts; Table 1

Version: medRxiv version 1, posted 2026-07-29
Retrieved: 2026-10-11T21:49:59Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.population

Source artifact SHA-256: 369746bfe0117866d294e01f49c6ffbfc2d177e347872030d6233e2e7366961e

Hash scope: artifact_sha256 describes one retrieval (2026-10-11T21:49:59Z). medRxiv regenerates this PDF: a reviewer download on 2026-10-12 had 2,761,577 bytes, SHA-256 3d37b32e8ff782201ed8ee6677a01808d4f8c86eea70350a530dde7306cab7c9 and PDF CreationDate 2026-10-11T20:08:12-07:00. The reviewer's copy's text layer matched every extracted value. The licence does not allow archiving.

Inspected artifact

Positives
254
Context-only references
An Evaluation of DMR-Informed Fine-Tuning of Tissue Array-Pretrained CpGPT for Gastrointestinal Cancer Classification Using cfDNA Targeted Methylation

Original source ↗

Methods, data sources and study cohorts; Table 1

Version: medRxiv version 1, posted 2026-07-29
Retrieved: 2026-10-11T21:49:59Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.positives

Source artifact SHA-256: 369746bfe0117866d294e01f49c6ffbfc2d177e347872030d6233e2e7366961e

Hash scope: artifact_sha256 describes one retrieval (2026-10-11T21:49:59Z). medRxiv regenerates this PDF: a reviewer download on 2026-10-12 had 2,761,577 bytes, SHA-256 3d37b32e8ff782201ed8ee6677a01808d4f8c86eea70350a530dde7306cab7c9 and PDF CreationDate 2026-10-11T20:08:12-07:00. The reviewer's copy's text layer matched every extracted value. The licence does not allow archiving.

Inspected artifact

Scope note
Public data generated by the EpiPanGI Dx study, not by the evaluating authors.
Context-only references
An Evaluation of DMR-Informed Fine-Tuning of Tissue Array-Pretrained CpGPT for Gastrointestinal Cancer Classification Using cfDNA Targeted Methylation

Original source ↗

Methods, data sources and study cohorts; Table 1

Version: medRxiv version 1, posted 2026-07-29
Retrieved: 2026-10-11T21:49:59Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.scope_note

Source artifact SHA-256: 369746bfe0117866d294e01f49c6ffbfc2d177e347872030d6233e2e7366961e

Hash scope: artifact_sha256 describes one retrieval (2026-10-11T21:49:59Z). medRxiv regenerates this PDF: a reviewer download on 2026-10-12 had 2,761,577 bytes, SHA-256 3d37b32e8ff782201ed8ee6677a01808d4f8c86eea70350a530dde7306cab7c9 and PDF CreationDate 2026-10-11T20:08:12-07:00. The reviewer's copy's text layer matched every extracted value. The licence does not allow archiving.

Inspected artifact

Source location
Methods, data sources and study cohorts; Table 1
Context-only references
An Evaluation of DMR-Informed Fine-Tuning of Tissue Array-Pretrained CpGPT for Gastrointestinal Cancer Classification Using cfDNA Targeted Methylation

Original source ↗

Methods, data sources and study cohorts; Table 1

Version: medRxiv version 1, posted 2026-07-29
Retrieved: 2026-10-11T21:49:59Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.source_locator

Source artifact SHA-256: 369746bfe0117866d294e01f49c6ffbfc2d177e347872030d6233e2e7366961e

Hash scope: artifact_sha256 describes one retrieval (2026-10-11T21:49:59Z). medRxiv regenerates this PDF: a reviewer download on 2026-10-12 had 2,761,577 bytes, SHA-256 3d37b32e8ff782201ed8ee6677a01808d4f8c86eea70350a530dde7306cab7c9 and PDF CreationDate 2026-10-11T20:08:12-07:00. The reviewer's copy's text layer matched every extracted value. The licence does not allow archiving.

Inspected artifact

Total
300
Context-only references
An Evaluation of DMR-Informed Fine-Tuning of Tissue Array-Pretrained CpGPT for Gastrointestinal Cancer Classification Using cfDNA Targeted Methylation

Original source ↗

Methods, data sources and study cohorts; Table 1

Version: medRxiv version 1, posted 2026-07-29
Retrieved: 2026-10-11T21:49:59Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.total

Source artifact SHA-256: 369746bfe0117866d294e01f49c6ffbfc2d177e347872030d6233e2e7366961e

Hash scope: artifact_sha256 describes one retrieval (2026-10-11T21:49:59Z). medRxiv regenerates this PDF: a reviewer download on 2026-10-12 had 2,761,577 bytes, SHA-256 3d37b32e8ff782201ed8ee6677a01808d4f8c86eea70350a530dde7306cab7c9 and PDF CreationDate 2026-10-11T20:08:12-07:00. The reviewer's copy's text layer matched every extracted value. The licence does not allow archiving.

Inspected artifact

Version
GEO GSE149438 as used by Xu and Feng 2026
Context-only references
An Evaluation of DMR-Informed Fine-Tuning of Tissue Array-Pretrained CpGPT for Gastrointestinal Cancer Classification Using cfDNA Targeted Methylation

Original source ↗

Methods, data sources and study cohorts; Table 1

Version: medRxiv version 1, posted 2026-07-29
Retrieved: 2026-10-11T21:49:59Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.version

Source artifact SHA-256: 369746bfe0117866d294e01f49c6ffbfc2d177e347872030d6233e2e7366961e

Hash scope: artifact_sha256 describes one retrieval (2026-10-11T21:49:59Z). medRxiv regenerates this PDF: a reviewer download on 2026-10-12 had 2,761,577 bytes, SHA-256 3d37b32e8ff782201ed8ee6677a01808d4f8c86eea70350a530dde7306cab7c9 and PDF CreationDate 2026-10-11T20:08:12-07:00. The reviewer's copy's text layer matched every extracted value. The licence does not allow archiving.

Inspected artifact

Description
Plasma cfDNA targeted bisulfite sequencing of 254 gastrointestinal cancers and 46 non-cancer controls from the EpiPanGI Dx study.
Context-only references
An Evaluation of DMR-Informed Fine-Tuning of Tissue Array-Pretrained CpGPT for Gastrointestinal Cancer Classification Using cfDNA Targeted Methylation

Original source ↗

Methods, data sources and study cohorts; Table 1

Version: medRxiv version 1, posted 2026-07-29
Retrieved: 2026-10-11T21:49:59Z

not individually reviewed

No individual claim review recorded

Audit details

Field: description

Source artifact SHA-256: 369746bfe0117866d294e01f49c6ffbfc2d177e347872030d6233e2e7366961e

Hash scope: artifact_sha256 describes one retrieval (2026-10-11T21:49:59Z). medRxiv regenerates this PDF: a reviewer download on 2026-10-12 had 2,761,577 bytes, SHA-256 3d37b32e8ff782201ed8ee6677a01808d4f8c86eea70350a530dde7306cab7c9 and PDF CreationDate 2026-10-11T20:08:12-07:00. The reviewer's copy's text layer matched every extracted value. The licence does not allow archiving.

Inspected artifact

How to read the evidence

Sources and history

Release 2026-11-21-c8bea25e5abb · Record review: source checked

1 source record and release historyDownload this release (gzip)
Technical metadata and record identifiers

Technical metadata for this record is tracked under stable ID ctdnalit-20261011-cpgpt2026-data-epipangi-gse149438.

Source locator: Methods, data sources and study cohorts; Table 1

Related records

Suggest a correction